Reference
Baek DW, et al. Clinical effects of hypomethylating agents in patients with newly diagnosed myelodysplastic syndrome who received DNA-damaging chemotherapy for metastatic breast cancer. Journal of Breast Cancer 22: 647-652, No. 4, 5 Nov 2019. Available from: URL: http://doi.org/10.4048/jbc.2019.22.e50
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1788, 36 (2020). https://doi.org/10.1007/s40278-020-74159-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-74159-6